Track CVRx Inc. Common Stock — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

CVRx Inc. Common Stock CVRX · Stock Open CVRx Inc. Common Stock in new tab

0.6074 USD
EPS
-2.00
P/B
1.25
ROE
-172.16
Beta
0.76
Target Price
1.65 USD
CVRx Inc. Common Stock logo

CVRx Inc. Common Stock

🧾 Earnings Recap – Q3 2025

CVRx posted a strong third quarter with a 10% year-over-year revenue increase, driven by strategic sales force enhancements and expanded commercial reach.

  • Revenue reached $14.7 million, with U.S. sales growing to $13.5 million, reflecting robust heart failure business expansion.
  • The company onboarded 10 new active implanting centers, bringing the total to 250, alongside a growth in sales territories to 50.
  • Momentum in adoption of Barostim therapy is underscored by more than 20% of centers performing three or more implants in Q3.
  • Advancements in reimbursement, including a proposed Category I CPT code effective January 2026, are expected to improve physician payment structures.
  • A strong presence at the Heart Failure Society of America meeting highlighted growing interest and clinical validation of Barostim therapy.
📅
Loading chart...
Key Metrics
Earnings dateFeb. 11, 2027
EPS-2.00
Book Value0.49
Price to Book1.25
Debt/Equity429.77
% Insiders10.322%
Growth
Revenue Growth-0.06%
Estimates
Forward P/E-0.32
Forward EPS-1.88
Target Mean Price1.65

DCF valuation

Model fair value for CVRx Inc. Common Stock (CVRX)
Result
Sign in to run the valuation for CVRX.
Assumptions
Growth– Capex– Tax– Terminal g– Cost of equity– Cost of debt–
Analyst price targets
5 analysts · consensus Hold · mean target 1.65 USD (low 1.25, high 2.00) · as of 15 Nov 2026
Low 1.25
Mean 1.65
High 2.00
Price 0.6074
Published broker research as supplied by our market data feed, named by firm and dated; it does not identify individual analysts. Targets carry their last refresh date; rating changes can be a few days behind.

CVRx Inc. Common Stock Logo CVRx Inc. Common Stock Analysis (CVRX)

United States Health Care Official Website Stock

Is CVRx Inc. Common Stock a good investment? CVRx Inc. Common Stock (CVRX) is currently trading at 0.6074 USD. Market analysts have a consensus price target of 1.65 USD. This suggests a potential upside from current levels.

Earnings Schedule: CVRx Inc. Common Stock is expected to release its next earnings report on Feb. 11, 2027. The market consensus estimate for Forward EPS is -1.88.

Investor FAQ

Does CVRx Inc. Common Stock pay a dividend?

No, it does not currently pay a dividend.

What asset class is CVRx Inc. Common Stock?

CVRx Inc. Common Stock is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

When is the next earnings date?

The next earnings date is projected to be Feb. 11, 2027. The company currently has a trailing EPS of -2.00.

Company Profile

CVRx, Inc., a commercial-stage medical device company, engages in developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases in the United States, Germany, and internationally. The company offers Barostim, an implantable device that delivers electrical pulses to baroreceptors located in the wall of the carotid artery to counteract decreased baroreceptor signaling, and provides baroreflex activation therapy, which links the cardiovascular system to the autonomic nervous system. It sells its products through direct sales force, sales agents, and independent distributors. The company was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.

Exchange Ticker
NMS (United States) CVRX
Trades
No dividend information available for this instrument.
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion